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Background. Residual renal clearance has been shown to
be much more predictive of survival than peritoneal clearance.
There has been little data to support a target level of peritoneal
clearance. A retrospective study was therefore conducted to
see how the peritoneal Kt/V had affected the survival of anuric
patients in our center.
Methods. Over a period of 10 years, there were 150 peritoneal
dialysis patients with documented anuria. Their survival was
analyzed according to their baseline peritoneal Kt/V at the time
of documentation of anuria and at the time of their latest altered
peritoneal dialysis (PD) prescription (subsequent Kt/V).
Results. There were 90 females and 42 diabetics. The mean age
and duration of dialysis were 57.7 ± 14.7 and 44.1 ± 31.3 months,
respectively. The 2-year and 5-year survival rates were 88.7%
and 66.7%, respectively. We found that patients with baseline
peritoneal Kt/V below 1.67 had poorer survival after the docu-
mentation of anuria than those above [relative risk (RR) 1.985,
P = 0.01], although the baseline Kt/V was not an independent
risk factors in the whole group of patients. However, such effect
was mainly observed in female patients. The survival was iden-
tical between those with Kt/V above or below 1.80 (P = 0.98).
Among female patients, the group with baseline Kt/V 1.67 to
1.86 had the best survival, followed by those greater than 1.86
and lowest in those below 1.67 (P = 0.0016). For patients with
baseline Kt/V below 1.80, those with subsequent Kt/V above
1.76 had better survival than those below (P = 0.033).
Conclusion. Our data suggested that a negative effect of peri-
toneal Kt/V on survival is apparent at a level below 1.67 and
there exists a limit of its effect at around 1.80. We suggested
a minimal Kt/V target of 1.70 and an optimal target at 1.80 in
anuric patients based on survival data. Prospective randomized
study is required to confirm this finding.
Most studies, including the reanalysis of the CANUSA
study by Bargman et al, have demonstrated that renal
clearance, rather than peritoneal clearance, predicts sur-
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vival [1–3]. Better preservation of residual renal function
(RRF) with peritoneal dialysis (PD) over hemodialysis
[4] is one argument for a PD-first dialysis policy [5], and
may account for the commonly reported better patient
survival of PD patients in the first few years of dialysis [6,
7]. However, no matter how long the RRF can be main-
tained with PD, patients will ultimately lose their RRF
completely. The PD community has been looking for a
clearance target but a definite peritoneal clearance target
could not be generated from the ADEMEX study, which
failed to demonstrate improvement of survival with in-
creasing peritoneal clearance including the subgroup of
patients with RRF below 1 mL/min/1.73m2 [8]. The K-
DOQI recommendation of a total Kt/V target of 2.0 per
week [9] has not been established by interventional stud-
ies. The prospective randomized study on incident PD
patients in Hong Kong with initial renal Kt/V below 1.0
suggested a minimal target of total Kt/V be around 1.7
[10]. But there has been little data to show how far peri-
toneal clearance or Kt/V would affect patient survival,
and what the peritoneal clearance target in anuric pa-
tients should be. This study attempts to address this issue
from the data of a cohort of anuric PD patients.
METHODS
Patients
Peritoneal and renal clearance study has been per-
formed annually on every PD patients since 1993 in our
center. We retrospectively analyzed all chronic ambula-
tory PD (CAPD) and continuous cyclic PD (CCPD) pa-
tients who had documented permanent anuria, which was
defined by 24-hour urine collection less than 100 mL per-
sistently. Intermittent PD including nocturnal intermit-
tent PD or day ambulatory PD patients was excluded.
Data collection and definition
The annual assessment included Kt/V and creatinine
clearance estimation from 24-hour effluent dialysate
and urine collection, and peritoneal equilibration test.
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Demographic, clinical data, peritoneal transport ex-
pressed as creatinine dialysate to plasma ratio at 4 hours
of peritoneal equilibration test (D/P Cr), volume of peri-
toneal dialysate (PDF) used per day, peritoneal Kt/V, and
creatinine clearance at the time of the first documentation
of anuria were retrieved from patient’ record and named
‘baseline’ data. As some patients had subsequent change
of PD volume or frequency prescriptions, to reflect the
change in PD prescription on survival, the clearance data
obtained after the change were obtained and labeled as
‘subsequent’ data. For those without change in PD pre-
scriptions, their baseline data were also regarded as ‘sub-
sequent’ data because major change in clearance was not
anticipated. The renal Kt/V in patients with urine less
than 100 mL/day was neglected in this study. Survival data
were collected by September 1, 2003, with conversion to
permanent hemodialysis (HD) and transplantation being
censored. Death within 3 months after transferral to HD
was regarded as mortality under PD. Survival was cal-
culated from the date of documentation of anuria until
censoring date or death.
Statistic methods
Numeric values for continuous valuables are expressed
in mean ± SD. Student t test was used to compare numeric
data between 2 groups, and analysis of variance was used
for multiple group comparison. Cox proportional hazards
model was used to study the relative risk (RR) of mortal-
ity for various factors. Backward stepwise elimination was
used to identify independent risk factors adjusted to age
and diabetes mellitus. Kaplan-Meier survival analysis was
used to compare survival between different groups. Sta-
tistical analysis was performed using SPSS 11.5 (Chicago,
IL, USA).
RESULTS
One hundred and fifty patients (149 CAPD and 1
CCPD patient), including 42 diabetics (28%), with docu-
mented permanent anuria were identified over a 10-year
period. The male to female ratio was 60:90. The timing of
first documentation of anuria was 44.1 ± 31.3 months on
PD with a mean age of 57.7 ± 14.7. The mean follow-up
duration after anuria was 50.0 ± 31.3 months. The de-
mographic, clearance, and peritoneal transport data are
shown in Table 1.
A total of 41 patients had changed PDF volume pre-
scription during the follow-up period, among which only
4 had reduced PDF volume prescription. The mean sub-
sequent peritoneal Kt/V and creatinine clearances were
1.92 ± 0.85 and 52.6 ± 7.7 L/week/1.73m2, respectively.
Sixty-one patients died, 11 were transferred to HD,
7 were transplanted, and 6 were transferred to other
centers. Sixty-five patients were still on PD by the time
Table 1. Baseline demographic, peritoneal dialysis prescription,
clinical and clearance data at the time of first documentation of anuria
in 150 patients
Mean SD (range)
Age 58.1 14.0 (23.1–84.3)
Duration of dialysis months 44.1 31.3 (0.76–170.9)
Body weight kg 56.0 9.9 (35.3–100.7)
Body mass index kg/m2 22.6 3.4 (17.8–36.1)
PD fluid L/day 6.70 1.13 (4.5–11)
Peritoneal Kt/V 1.74 0.29 (1.10–2.63)
Peritoneal CCl L/wk/1.73 m2 50.5 8.5 (32.6–78.0)
D/P creatinine, 4 hours 0.72 0.12 (0.34–0.99)
Serum albumin g/L 35.0 4.6 (22–49)
Hemoglobin g/dL 8.3 1.9 (5.0–13.5)
of data collection. The 1-, 2-, 3-, 5-, and 8-year patient
survival after anuria documentation was 94.6%, 88.7%,
80.4%, 66.6%, and 38.2%, respectively. The respective
combined patient and technique survivals were 94.6%,
88.7%, 79.6%, 64.1%, and 31.8%. The causes of death
were cardiovascular-related problems (21 patients, 34%),
infection other than peritonitis (21 patients, 34%), peri-
tonitis (8 patients, 13%), malignancy (3 patients, 5%),
cerebrovascular disease (2 patients, 3%), unknown, or
others (6 patients, 10%).
With Cox proportional hazard survival analysis, age
(RR=1.082 for every one year older, 95%CI 1.051–1.114,
P = 0.000), diabetes mellitus (RR = 2.062, 1.198–5.349,
P = 0.009), and D/P Cr (RR = 1.505 for every 0.1
increase, 1.202–1.885, P = 0.000) were strong indepen-
dent predictors for mortality. The baseline Kt/V was not
predictive of mortality (RR = 0.919 for every 0.1 in-
crease, 0.833–1.014, P = 0.094). Creatinine clearance,
both baseline and subsequent value, and gender were
not associated with the risk of mortality. The timing of
documentation of anuria did not predict subsequent sur-
vival but predicted the overall survival calculated from
the commencement of chronic PD (RR = 0.962 for every
1 month delay, 0.949–0.974, P = 0.000).
Table 2 shows the effect of various baseline Kt/V cut-
off value on patient survival by Kaplan-Meier analysis.
It was found that the best cut-off level for the baseline
Kt/V in predicting subsequent survival was at 1.67. The
survival curves for patients with baseline Kt/V above and
below 1.67 are shown in Figure 1. There was no statisti-
cal significance difference in age (Kt/V below 1.67: 57.5 ±
13.7, 1.67 or above: 58.6 ± 14.3, P = 0.64) and diabetic pa-
tient proportion (Kt/V below 1.67: 33.3%, 1.67 or above:
24.4%, P = 0.268) between the 2 groups. As expected,
there were more male patients in the group with peri-
toneal Kt/V below 1.67 (38 in 60 patients, P = 0.000). The
relative risk of mortality for Kt/V below 1.67 after ad-
justment to age and diabetes mellitus was 1.985 (95%CI
1.184–3.329, P = 0.01). When the cut-off value was set at
1.80 or above, the survival curves were almost identical
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Fig. 1. Unadjusted cumulative survival of patients according to their
baseline Kt/V at initial documentation of anuria. Continuous line repre-
sents patients with Kt/V above or equal to 1.67 (N = 90). Bold broken
line represents patients with Kt/V below 1.67 (N = 60). The survival
difference was statistically significant (P = 0.0269).
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Fig. 2. Unadjusted cumulative survival of patients according to their
baseline Kt/V at initial documentation of anuria. Continuous line repre-
sents patients with Kt/V above or equal to 1.80 (N = 64). Bold broken
line represents patients with Kt/V below 1.80 (N = 86). The survival
rates were almost identical (P = 0.9786).
for those above and below (Fig. 2). This showed that the
survival advantage was lost when the baseline peritoneal
Kt/V was above 1.80.
However, the effect of baseline Kt/V on survival was
only observed in female patients. The survival difference
was observed with Kt/V cut-off value at 1.67 (P = 0.0024,
Fig. 3), and gradually became identical when approaching
1.80. For male patients, the survival curves were more or
less identical with a Kt/V cut-off value ranging from 1.50
to 1.80 (P value from 0.41 to 0.86, Fig. 4). The lack of
impact of Kt/V on survival in male patients was not due
to a high transferral to HD or transplantation because
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Fig. 3. Unadjusted cumulative survival of female patients according to
their baseline Kt/V at initial documentation of anuria. Continuous line
represents patients with Kt/V above or equal to 1.67 (N = 68), and bold
broken line represents patients with Kt/V below 1.67 (N = 22). The
survival difference was statistically significant (P = 0.0024). It was not
statistically significant when the Kt/V cut-off was made at 1.70 or above.
The two survival curves become almost identical when Kt/V cut-off was
made at 1.80.
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Fig. 4. Unadjusted cumulative survival of male patients according to
their baseline Kt/V at initial documentation of anuria. Continuous line
represents patients with Kt/V above or equal to 1.67 (N = 40), and bold
broken line represents patients with Kt/V below 1.67 (N = 22). The
survival difference was not statistically significant (P = 0.7098). It was
not statistically significant at any Kt/V cut-off values. The two survival
curves were almost identical when Kt/V cut-off was made at 1.70 (P =
0.8626).
there were only 3 such patients out of 45 male patients
and 4 out of 41 female patients with baseline Kt/V below
1.70.
Female patients were further divided into 3 groups ac-
cording to their baseline peritoneal Kt/V. Group 1: those
with Kt/V below 1.67, group 2: Kt/V between 1.67–1.86,
group 3: Kt/V 1.87 or above. The dividing line at 1.87 was
the median of the Kt/V values of all female patients with
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Table 2. Statistical values of various baseline peritoneal Kt/V cut-off
levels for subsequent survival of anuric patients (N = 150) according
to Kaplan-Meier analysis
Kt/V value Number of patients P value
<1.90 108 0.9790
<1.80 86 0.9786
<1.70 67 0.1430
<1.67 60 0.0269
<1.65 53 0.0507
<1.60 47 0.0601
<1.50 33 0.1640
Table 3. Demographic and clinical data of the three groups of female
patients according to their baseline peritoneal Kt/V at documentation
of anuria
Group 1 Group 2 Group 3 P value
Kt/V range <1.67 1.67–1.86 ≥1.87
Number of patients 22 33 35
Number of diabetics 6 6 10 0.572
Age 61.3 ± 13.6 57.3 ± 14.8 57.2 ± 14.7 0.533
Body weight kg 58.5 ± 9.0 51.9 ± 6.1 50.4 ± 8.8 0.001
BMI kg/m2 25.0 ± 3.9 22.2 ± 2.5 22.0 ± 3.4 0.002
D/P creatinine 0.70 ± 0.11 0.69 ± 0.13 0.73 ± 0.12 0.329
Duration of 45.0 ± 38.7 45.5 ± 33.4 44.0 ± 34.1 0.985
dialysis months
PDF volume L/day 5.77 ± 0.75 6.15 ± 0.51 6.97 ± 1.01 0.000
Serum albumin g/L 33.6 ± 4.8 34.8 ± 3.8 36.0 ± 5.9 0.202
Abbreviations are: BMI, body mass index; PDF, prescribed peritoneal
dialysate fluid.
Kt/V 1.67 or above. There was no demographic and clin-
ical data difference between group 2 and 3 except that
group 3 patients used more PDF per day. Apart from us-
ing less PDF, group 1 patients also had higher body weight
and body mass index (Table 3). It was found that the group
2 patients had the best survival, and group 1 patients
had lowest survival according to Kaplan-Meier analysis
(P = 0.0016, between group 1 and 2, P = 0.0004, between
group 2 and 3, P = 0.0285, Fig. 5). Older age, heavier
body weight, higher body mass index, higher peritoneal
transport were also found to be independent risk factors
for mortality. The prescribed daily PDF volume was not.
After controlling for these factors with Cox regression,
analyzed as a whole group or separately for diabetics and
nondiabetics, Kt/V group was still a significant risk fac-
tor for mortality, with lowest risk in group 2 consistently,
and significantly worse outcome in group 1 nondiabetic
patients and group 3 diabetic patients (Table 4).
To determine the effect of subsequent change in PD
prescription and peritoneal clearance on patients with
baseline Kt/V less than 1.80 (N = 86), a statistically
significant lower survival was found with patients with
subsequent Kt/V with less than 1.76. Table 5 shows the
statistical value of different subsequent Kt/V cut-off val-
ues among patients with baseline Kt/V less than 1.80.
Among female patients, a trend toward better survival
in those with baseline Kt/V below 1.80, but with subse-
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Fig. 5. Unadjusted cumulative survival of female patients according
to their baseline Kt/V at initial documentation of anuria. Continuous
line represents patients with Kt/V between 1.67 and 1.86 (N = 33),
dashed line represents patients with Kt/V 1.87 or above (N = 35), and
bold dotted line represents patients with Kt/V below 1.67 (N = 22).
The survival difference was statistically significant (P = 0.0016). The
difference between patients with Kt/V below 1.67 and those between
1.67 and 1.86 was significant (P = 0.004), and also between patients with
Kt/V 1.67 and 1.86, and those 1.87 or above (P = 0.0285)
Table 4. Relative risk of different peritoneal Kt/V groups at
documentation of anuria in female diabetic and nondiabetic patients,
after adjustment to age, according to Cox proportional hazard model
All female patients (90 patients)
Kt/V Reference RR 95%CI P value
Kt/V groups 0.009
<1.67 1.67–1.86 4.482 1.804–11.1 0.001
≥1.87 1.67–1.86 2.401 1.017–5.665 0.046
(<1.67 ≥1.87 1.867 0.852–4.091 0.119)
Nondiabetics (68 patients)
Kt/V Reference RR 95%CI P value
Kt/V groups 0.014
<1.67 1.67–1.86 4.441 1.621–12.17 0.004
≥1.87 1.67–1.86 1.396 0.510–3.817 0.516
(<1.67 ≥1.87 3.182 1.190–8.529 0.021)
Diabetics (22 patients)
Kt/V Reference RR 95%CI P value
Kt/V groups 0.035
<1.67 1.67–1.86 5.406 0.654–49.8 0.115
≥1.87 1.67–1.86 10.12 1.29–79.0 0.027
(<1.67 ≥1.87 0.564 0.115–2.756 0.479)
quent Kt/V above 1.75 was observed (P = 0.139). The
relative risk of subsequent Kt/V in the female patients
with baseline Kt/V below 1.80 was statistically insignifi-
cant (RR = 0.977 for every 0.1 increase, 0.780–1.224, P =
0.84). But in male patients, the relative risk for every 0.1
increase in subsequent Kt/V was 1.026 (1.002–1.050, P =
0.037); however, it was not significant after adjustment to
age and diabetes mellitus (P = 0.084).
We divided those patients with baseline Kt/V <1.80
into 3 groups. Group A: both baseline Kt/V and subse-
quent Kt/V <1.70 (N = 37), group B: baseline Kt/V <1.70
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Table 5. Statistical values of various subsequent peritoneal Kt/V
values in anuric patients with baseline peritoneal Kt/V values below
1.80 (N= 86) by Kaplan-Meier analysis
Kt/V value Number of patients P value
<1.80 52 0.3802
<1.77 46 0.2795
<1.76 43 0.0334
<1.75 42 0.0511
<1.70 37 0.0549
<1.60 31 0.2128
but subsequent Kt/V >1.70 (N = 34), group C, both base-
line and subsequent Kt/V >1.70 (N = 15). After adjust-
ment to age, diabetes mellitus, and D/P creatinine, both
group A and B patients had significantly higher relative
risk of mortality compared to group C, (group A RR =
4.34, 1.26–14.16, P = 0.014, group B RR = 4.12, 1.31–13.0,
P = 0.016), but it was not significant when only group A
and B were compared to each other.
DISCUSSION
Peritoneal clearance has not been found to be as-
sociated with patient survival in patients with signifi-
cant residual renal functions virtually in all studies. The
data on anuric patient have been quite contradicting.
Bhaskaran et al reported that a higher mortality was
found in 89 anuric patients with Kt/V below 1.85, but
it was not statistically significant (P = 0.10), and the asso-
ciation with creatinine clearance was even weaker [11].
Szeto et al found that an increase in peritoneal Kt/V by 0.1
was associated with a reduction of relative risk of mor-
tality by 6% in a cohort of 140 anuric patients, and an
increase in creatinine clearance by 5 L/week/1.73m2 was
associated with a 12% reduction in mortality [12]. A
large-scale cross-sectional study of 937 patients in Hong
Kong did not find predictive power of peritoneal clear-
ance on survival among the 446 anuric patients [13]. Simi-
lar to the ADEMEX study, interventional study on anuric
patients had not shown improvement of patient survival
by increasing peritoneal clearance. Szeto et al increased
PD prescription in 50 out of 100 anuric patients, but there
was no improvement of 2 years’ survival or other clinical
parameters apart from an increase in nitrogen appear-
ance rate [14]. On the other hand, Szeto et al recently
showed that although baseline peritoneal clearance did
not predict survival in a cohort of 120 incident and 150
prevalent patients, with a progressive increase in peri-
toneal Kt/V as a result of change in PD prescription over
a 5-year period of the study, he observed that lower aver-
aged peritoneal Kt/V was a significant risk factor for mor-
tality in the group of prevalent patients who had lower
RRF than incident patients [15]. It may mean that the
change of peritoneal Kt/V would affect outcome, but it
may also be due to a bias arising from the averaged peri-
toneal Kt/V (see below). In clinical practice, we should
have experienced clinical improvement after increasing
the dialysis in some patients with low peritoneal clear-
ance. The issue is whether there exists a peritoneal Kt/V
target that would show survival benefits.
In this study, we found that although the baseline peri-
toneal Kt/V did not predict survival after adjustment to
age and diabetes mellitus, patients with baseline Kt/V be-
low 1.67 had a significantly poorer patient survival, mainly
confined to female patients. This survival benefit is totally
lost when the cut-off Kt/V was made at 1.80. This find-
ing implies that not just the beneficial effect of peritoneal
Kt/V levels off at 1.80, but there may be a further asso-
ciation of higher mortality with higher peritoneal Kt/V.
This was confirmed when the female patients were subdi-
vided into 3 different Kt/V groups and adjusted for vari-
ous confounding factors, a ‘V’ shaped curve of mortality
risk was found, with the lowest risk found in the group
with Kt/V 1.67 to 1.86. The risk in the group with Kt/V
above 1.87 was slightly higher than the group between
1.67 and 1.86, particularly in the diabetics. The highest risk
was found in the group with Kt/V below 1.67, particularly
for the nondiabetic patients. The paradoxic increased risk
with Kt/V above 1.87 was not accountable by clinical or
demographic differences. Though patients in this group
had smaller body weight, the similar body mass index
and serum albumin to group 2 indicated that they were
not particularly malnourished. It is noteworthy that pa-
tients in this group used most peritoneal dialysate per
day. Their higher Kt/V was the result of using more peri-
toneal dialysate. While less PDF used leads to inadequate
dialysis and poorer survival is easily understandable, the
association of higher PDF volume used and increased
risk in this group is rather unexpected. It means that it
may be a result of ‘PDF toxicity’ (e.g., excessive ultrafil-
tration, more glucose absorbed), or this group of patients
had more fluid and clinical problems, requiring more daily
exchanges before they developed anuria and, therefore,
they were high-risk patients intrinsically. We think the lat-
ter possibility is more likely. We should not jump to the
conclusion that high peritoneal Kt/V has a causal nega-
tive impact on survival because unrecognized confound-
ing factors might still be present in a retrospective study,
and this finding was mainly found in female patients. We
need to examine if the same biphasic effect is found in
other studies.
The reason why the effect of Kt/V on survival was only
found in female patients was unclear. It could be related
to smaller number of male patients, but such a trend was
not even observed in male patients. It was not explain-
able by body weight differences between genders either.
Though higher Kt/V dose was also associated with higher
mortality risk in male patients in the HEMO study [16],
we have no intention to draw a direct analogy between
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the 2 studies because the Kt/V from hemodialysis cannot
be compared to peritoneal Kt/V directly. Due to small
number of patients, we do not consider our current data
among the male patients as definitive.
The level of Kt/V below which survival is clearly jeop-
ardized should be defined as the minimal Kt/V target,
and the level above which no any further improvement
is achievable should be defined as the optimal target.
From our data, the minimal peritoneal Kt/V target in
anuric patients should, therefore, be 1.67, and to round
up the figure, 1.70. The optimal Kt/V target should be
around 1.80. This is surprisingly quite similar to our ear-
lier suggestion of a minimal total Kt/V of 1.70 from a ran-
domized, prospective, interventional study on incident
patients [10]. Could this cut-off level be a result happened
by chance from trial and error on different cut-off val-
ues? We believe that it was not because there existed a
definite progressive diminishing effect of raising the peri-
toneal Kt/V cut-off value until it reaches the plateau at
1.80. The reason that an even lower cut-off value below
1.65 did not yield statistical significant result was likely
due to inadequate power as a result of too little patients
in the group below the cut-off value.
The existence of a biphasic effect of peritoneal Kt/V
on survival may explain why the Kt/V was not a signifi-
cant risk factor with Cox regression model in this study,
and may even be the reason for the very variable result
of the effect of peritoneal Kt/V on many observatory
reports mentioned above. Another reason why a base-
line Kt/V did not predict survival is that there may be
changed dialysis prescriptions afterwards. An averaged
Kt/V over time may be a better index than baseline Kt/V.
However, it would be affected by the survival time of
a patient. For example, a patient who died shortly after
an increase in dialysis prescription will have a lower av-
eraged Kt/V compared to one who survives many years
after the increase, while both are actually given the same
prescription. In this way, early mortality will be found to
be associated with a lower averaged Kt/V. Furthermore,
as there is a trend toward increasing PDF prescription
with the loss of RRF with time, one who died earlier
will have lower averaged peritoneal Kt/V. Furthermore,
the Kt/V is affected by body weight changes. One who
has progressive wasting will increase Kt/V spontaneously.
There is probably no ideal methodology of analyzing the
effect of the changing Kt/V. In clinical practice, we usu-
ally assess the risk according to a patient’s current clear-
ance, rather than an averaged clearance over a period
of time. We would modify the prescription and reassess
the risk after the change. To simulate this clinical prac-
tice, we further analyze our data according to their subse-
quent Kt/V, which was defined by their latest Kt/V if they
had prescription changed. We found that among anuric
patients with suboptimal peritoneal Kt/V (i.e., less than
1.80), those with subsequent Kt/V 1.76 or above had bet-
ter survival than those below 1.76. This indicates that the
higher mortality in these patients may be reversible with
subsequent increase in dialysis, but it may as well be a
bias arising from early mortality, reducing the chance for
subsequent increase in peritoneal dialysis as mentioned
above. When we divided these patients with suboptimal
Kt/V into 3 groups—those maintained with Kt/V above
1.7 (the minimal target) throughout, those with baseline
Kt/V below 1.7 but the subsequent change producing
a Kt/V higher than 1.70, and one group with Kt/V be-
low 1.70 throughout—the latter 2 groups had mortality
risk around 4 times that of those with Kt/V maintained
above the minimal target throughout. It was noted that
for patients with subminimal Kt/V, the risk was not signif-
icantly reduced when the subsequent Kt/V was increased
to above 1.70. This information suggests that we should
prevent our patients’ peritoneal Kt/V from falling be-
low 1.70 when the patient is approaching anuria. In other
words, the total Kt/V has to be kept above 1.70 at all
times, in line with our previous suggested minimal total
Kt/V of 1.70 [10]. It may be too late to increase the dialysis
dose after total Kt/V falls below 1.70. On the other hand,
it is rather intriguing to find that the higher subsequent
Kt/V was associated with higher mortality risk in male
patients, although it was not statistically significant after
adjustment to age and diabetes mellitus. The effect of
peritoneal Kt/V on male patients’ survival needs further
investigation, with a much larger sample of patients.
This study also supports the importance of RRF in sur-
vival of patients as we demonstrated the earlier the onset
of anuria, the poorer the overall survival though the tim-
ing of onset did not predict subsequent survival. Every 1-
month delay in the onset of anuria was associated with a
3.8% reduction in mortality risk. Therefore, maintaining
RRF for a longer period is important for patient survival.
CONCLUSION
Our data suggested a minimal peritoneal Kt/V target
of 1.70 and an optimal target of 1.80 in anuric patients.
We should prevent the total Kt/V from falling below 1.70
while the patients were still having some residual renal
function. This is particularly important for patients who
still depend on their residual renal function to make up
to the clearance target. The existence of an optimal peri-
toneal Kt/V means that there is a limit of the effect of
peritoneal clearance on patient survival. Increasing peri-
toneal dialysis beyond this level had not been shown to
yield beneficial effect on survival. The peritoneal Kt/V
should be best kept at around 1.80 in anuric patients.
This finding is consistent with the absence of survival im-
provement in the treated arm of ADEMEX study with
peritoneal Kt/V increased from a mean of 1.70 to 2.1,
even in the group of patients with residual renal function
less than 1 mL/min/1.73m2 [8]. However, in view of the
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retrospective nature of this study, these Kt/V values can-
not be regarded as definitive. Though we did not show a
relationship between Kt/V and survival in male patients,
the minimal Kt/V target should better be applied to male
patients as well. Prospective, randomized, interventional
study in a much larger pool of patients is needed to con-
firm the positive or negative effect or existence of an ef-
fect limit of peritoneal Kt/V on survival of anuric patients.
Before we have more definitive data, it is not justifiable to
reduce patients’ PD prescription to bring the peritoneal
Kt/V down to 1.8.
Reprint requests to Dr. W.K. Lo, Department of Medicine, Tung Wah
Hospital, 12 Po Yan Street, Hong Kong.
E-mail: wkloc@hkucc.hku.hk
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